- Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. Beckers, N.G., Macklon, N.S., Eijkemans, M.J., Ludwig, M., Felberbaum, R.E., Diedrich, K., Bustion, S., Loumaye, E., Fauser, B.C. J. Clin. Endocrinol. Metab. (2003)